PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
29-Sep-2022 DEFENCE THERAPEUTICS IS GRANTED PATENTS IN JAPAN AND ISRAEL EXPANDING ITS NOVEL ADC PLATFORM TECHNOLOGY IN THE FAST GROWING ANTIBODY-DRUG CONJUGATES MARKET Defence Therapeutics Inc.
28-Sep-2022 MorphoSys Presents New Long-Term Data from L-MIND Suggesting Durable Response to Treatment with Monjuvi® (tafasitamab-cxix) for Patients with R/R DLBCL MorphoSys AG
28-Sep-2022 RetinAI Expands Operations with a U.S. Office In Boston and Achieves 21 CFR Part 11 Compliance to Support Research and Clinical Studies RetinAI Medical AG
28-Sep-2022 ProtonDx Awarded £365,000 Defra and Innovate UK Grant to Develop Porcine Lung Disease Diagnostic ProtonDx Ltd
28-Sep-2022 Pneumagen Creates International Clinical Advisory Group of World Leading Respiratory and Infectious Disease Experts Pneumagen
28-Sep-2022 ProtonDx Awarded £365,000 Defra and Innovate UK Grant to Develop Porcine Lung Disease Diagnostic B3C newswire
28-Sep-2022 Brandon Capital co-Leads USD68M Series A Financing of London-Based ADC Company Pheon Therapeutics Brandon Capital
28-Sep-2022 Availability of the Q3 2022 Memorandum for modelling purposes Sanofi
28-Sep-2022 Result of AGM Spectral MD Holdings, Ltd.
28-Sep-2022 Pureos Partners Welcomes Dr. Veronica Gambillara Fonck as New Partner to its Investment Team B3C newswire
28-Sep-2022 Xlife Sciences with pleasing progress in the first half of 2022 Xlife Sciences AG
27-Sep-2022 ABIVAX ABSTRACT ON OBEFAZIMOD PHASE 2B RESULTS SELECTED FOR MODERATED POSTER PRESENTATION AT UEG WEEK 2022 ABIVAX
27-Sep-2022 Fagron launches excipients line DiluCap - making capsule formulation easier and more reliable Fagron
27-Sep-2022 Tezspire approved for a broad population of patients with severe asthma with no phenotype or biomarker limitations AstraZeneca
27-Sep-2022 World Pharmacists Day: UK pharmacists join the celebration of the changing face of modern pharmacy to create healthier futures Alliance Healthcare
27-Sep-2022 TEZSPIREā–¼(tezepelumab) AUTHORISED IN GREAT BRITAIN FOR THE TREATMENT OF SEVERE UNCONTROLLED ASTHMA AstraZeneca
27-Sep-2022 Change in the Executive Management Board of BRAIN Biotech AG, genome editing activities established under the Akribion Genomics brand BRAIN Biotech AG
26-Sep-2022 BRAIN Biotech AG sells subsidiary L.A. Schmitt to a URI group company BRAIN Biotech AG
26-Sep-2022 SeraNovo and Ildong Pharmaceutical to Collaborate on Research Projects B3C newswire
26-Sep-2022 MediClin AG: MEDICLIN plans to close the Schlüsselbad Klinik in Bad Peterstal by the end of 2022, subject to the outcome of the consultations with the works council MediClin AG